HTB

Treatment access

UK gives £15.7m to Burmese HIV project

Death of South African AIDS activist fuels anger

The City turns up the heat on drug companies to make treatment available in poorest countries

Lancet commentary concludes that prevention and treatment in South Africa are affordable and desirable

South Africa treatment protests go global

Gilead to sell tenofovir at cost to 68 countries

New advocacy coalition demands emergency funding from rich governments for Global Fund

NIH/NIAID study of generic drugs shows results consistent with stringent manufacturing standards

Global Fund gives $210 million for treatment in Thailand

Anti-HIV combination drug for Indonesia

Indian generic drug maker Ranbaxy Laboratories to launch own-brand abacavir

Bush blocks deal allowing cheap drugs

Roche to sell nelfinavir, saquinavir at cost to least-developed nations

South Africa appoints another dissident

Bush plans $15 billion budget to treat two million people and prevent seven million infections in 14 countries – but meets criticism from activists

The World Health Organisation must continue its work on access to medicines in developing countries

Dr Jong-Wook Lee nominated to be WHO director-general

AAI Pharma access programme providing treatment for 36,000 people in Africa

Pharmacia to launch pilot programme for expanding access to medicines in the poorest countries

Heineken to offer antirerotviral drug coverage to African workforce

Five pharmaceutical companies to halve antiretroviral drug prices for central America

Patent law overrides would not expand access to drugs for low-income nations, opinion piece says

Combination of three generic drugs in one pill meets bioequivalence criteria when compared with the branded drugs: Triomune vs d4T/3TC/NVP

Lancet special report examines direction new WHO director general should take on several HIV/AIDS-related issues

Europe steps in to protect discounted drugs for developing countries

Profiteers undermine preferential pricing and make millions diverting cheap drugs sent to Africa

Activists win court battle in campaign for generic production of ddI

Global AIDS fund facing bankruptcy

Excitement over anticipated approval of T-20 is balanced by fears that it will be the most expensive HIV drug yet

GlaxoSmithKline cuts drug prices to 63 countries

Bill Clinton and Nelson Mandela promise to lead peer education among political leaders as world looks for $10 billion a year to fight HIV/AIDS

South African activist unveils campaign to force compulsory licences

MSF study shows treatment in resource-poor settings is effective

‘Barcelona Declaration’ demands 2m poor people are treated in the next two years

Lives were lost as experts argued the merits of care versus prevention, says Stefano Vella

Peter Piot sets out the global political agenda in the fight against HIV/AIDS

Health should be a right, not a commodity, and medicine must be removed from the World Trade Organisation, argues key speaker

Governments must act to cut drug prices, says Kenya’s health minister

Civil society had to fight for universal access to AIDS drugs in Brazil

Coalitions of local NGOs can effectively demand access to medicines, reports MSF

Involvement of PLWHA is key to improving access to treatments

ART can successfully tackle advanced disease in resource poor settings, reports MSF

Investment in treatment and care significantly reduces company health and social expenditure in Abidjan

Financing the global response to the epidemic will cost $9.2 billion a year, according to one estimate

The Global Fund: what, where, how much?

Leading businesses spurn Global Fund

14 Caribbean governments sign cut-price drugs agreement with six pharmaceutical companies

Thailand offers low-cost transfer to African countries of technology for the local production of generic antiretrovirals

Informal market plays a role in distributing antiretrovirals but exposes clients to risks

Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1

US foundation bars GlaxoSmithKline representatives over AIDS drug pricing

WHO releases guidelines for use of antiretroviral drugs to treat HIV infection in developing countries (2002)

Mbeki backs down: he shuns dissidents and expands drug treatment programme

Early access programme offers adefovir for treatment of HBV

South Africa finds 1 billion Rand to treble HIV budget, after Mandela confronts Mbeki

Meeting calls for NHS funding and training to provide repair treatment for people with facial lipoatrophy

South African treatment activists defy patent laws to import generic antiretrovirals from Brazil

Survey reveals pregnant Zambians support universal nevirapine treatment

Drug companies’ spending on advertising double research and development spending in 2000

Nigeria to launch AIDS treatment program

Abbott Labs cuts prices on many drugs, treatments amid pricing investigation

Yale economist introduces proposal to settle debate between pharmaceutical companies and developing nations

Kenyan lawmakers approve bill to suspend drug patent rights and improve cheaper drug access

South African government issues first draft of legislation allowing importation of discounted pharmaceuticals

International aid group to begin administering AIDS drugs to small group of poor South Africans

Post navigation